Results for tag: "Lung Cancer Clinical Trial"

The Lung Cancer Clinical Trial market is a subset of the larger Lung Cancer Drugs market. It focuses on the development of new treatments and therapies for lung cancer, as well as the testing of existing treatments and therapies. Clinical trials are conducted to evaluate the safety and efficacy of new drugs and treatments, and to determine the best course of action for treating lung cancer. Clinical trials are conducted by pharmaceutical companies, research institutions, and universities. The Lung Cancer Clinical Trial market is highly competitive, with many companies vying for a share of the market. Companies such as AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche are all active in the Lung Cancer Clinical Trial market. Additionally, smaller companies such as ImmunoGen, Incyte, and Tesaro are also involved in the market. Show Less Read more